COVID-19: Adolescents aged 12 to 15 years experienced mild to moderate side effects after Pfizer vaccine | world News

[ad_1]

A study found that teens ages 12 to 15 who took Pfizer experienced mild to moderate side effects that faded quickly.

The vaccine has been given to adolescents in the age group at high risk of developing complications from coronavirus due to some coexisting conditions.

The authors said the findings should reassure parents as reports emerged that the NHS was making plans to start vaccinating all 12-15-year-olds from the first week back in school.

The NHS Trusts were told on Wednesday to prepare for a possible launch of a vaccination program for all school children in the age group, The Telegraph reported.

Emails seen by the paper, sent by NHS England regional offices, say funds should have plans ready by 4pm on Friday.

Health officials have reportedly said children will not need parental consent to receive an injection.

The study that looked at the use of the Pfizer vaccine in children ages 12 to 15 asked parents of 27 children who received the vaccine to report any side effects.

The authors of the study, which was published in the Archives of Childhood Diseases, said: “The numbers were small, but these data are especially important because they represent children most likely to benefit from vaccination, and parents and clinicians. You may have concerns about an increased risk of unexpected events.”

Of the 27 children, three were inpatients, 16 were boys and most, 21, were white.

They had various neurological conditions, including muscular dystrophy and cerebral palsy, as well as a range of concurrent medical conditions, such as epilepsy, congenital heart defects, and immunodeficiency, for which they were receiving treatment of various kinds.

All reported side effects were mild to moderate, with the exception of one child experiencing extreme tiredness and restlessness, along with increased agitation. One family also reported that the seizure type changed into groups, although this was resolved after a week.

In all, there were eight ‘events’ in six children after the first dose, and all resolved within 72 hours: mild rash, mild rash. Headache; Diarrhea; sore throat; neck pain; difficulty sleeping; And low blood sugar.

After the second dose, eight additional events occurred in five children: diarrhea; diarrhea; vomiting; Armpit swelling and blisters around the mouth.

Catch up on daily broadcasts on Apple Podcasts, Google Podcasts, Spotify and Spreaker

Paracetamol use after the first dose was high and fever was more common than reported in studies in adults (13% vs. 4% at 16-55 years of age).

But all recorded side effects disappeared within a week.

The study authors said that children considered to be at risk of contracting the coronavirus were protected during the pandemic because of their risk of infection and were not included in early vaccine safety studies.

Healthy children infected with the coronavirus generally have mild illness.

However, the Joint Committee on Vaccination and Immunization (JCVI), the UK Vaccine Advisory Group, has advised that children aged 12 years and over with severe neurological disabilities, who tend to have frequent respiratory infections and have complex care needs, should They are offered COVID-19 a jab.

[ad_2]